Licarbazepine
Alternative Names: GP-47779; LIC-477; LicarbazapineLatest Information Update: 03 Apr 2017
At a glance
- Originator Novartis
- Class Antidepressants; Antimanics; Dibenzazepines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bipolar disorders
Most Recent Events
- 01 Jul 2007 Novartis completes a phase III extension trial in Bipolar I disorders in USA (NCT00228059)
- 17 May 2005 Phase-III clinical trials in Bipolar disorders in Switzerland (PO)
- 04 Mar 2004 Phase-II clinical trials in Bipolar disorders in Switzerland (PO)